Background Image
Table of Contents Table of Contents
Previous Page  28 / 68 Next Page
Information
Show Menu
Previous Page 28 / 68 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 30, No 3, May/June 2019

156

AFRICA

10. Park MK.

Pediatric Cardiology for Practitioners.

St Louis: Mosby, 2002.

11. Eerola A, Jokinen E, Boldt T, Pihkala J. The influence of percutaneous

closure of patent ductus arteriosus on left ventricular size and function:

a prospective study using two- and three-dimensional echocardiography

and measurements of serum natriuretic peptides.

J Am Coll Cardiol

2006;

47

(5): 1060–1066. DOI: 10.1016/j.jacc.2005.09.067.

12. Davis GK, Bamforth F, Sarpal A, Dicke F, Rabi Y, Lyon ME. B-type

natriuretic peptide in pediatrics.

Clin Biochem

2006;

39

(6): 600–605.

DOI: 10.1016/j.clinbiochem.2005.12.004.

13. Li N, Wang J. Brain natriuretic peptide and optimal management of

heart failure

. J Zhejiang Univ Sci B

2005;

6

(9): 877–884. DOI:10.1631/

jzus.2005.B0877.

14. Mahfouz RA, Alzaiat A, Gad M. Association of aortic stiffness to

brain natriuretic peptide in children before and after device closure of

patent ductus arteriosus.

J Saudi Heart Assoc

2015;

27

(1): 23–30. DOI:

10.1016/j.jsha.2014.06.001.

15. Westerlind A, Wahlander H, Lindstedt G, Lundberg PA, Holmgren

D. Clinical signs of heart failure are associated with increased levels

of natriuretic peptide types B and A in children with congenital heart

defects or cardiomyopathy.

Acta Paediatr

2004;

93

(3): 340–345. DOI:

10.1111/j.1651-2227.2004.tb02958.x.

16. Mir TS, Falkenberg J, Friedrich B, Gottschalk U, Le TP, Laer S,

et al.

Levels of brain natriuretic peptide in children with right ventricular

overload due to congenital cardiac disease.

Cardiol Young

2005;

15

(4):

396–401. DOI:10.1017/s1047951105000831.

17. Bando K, Turrentine MW, Sharp TG, Sekine Y, Aufiero TX, Sun K,

et al

. Pulmonary hypertension after operations for congenital heart

disease: analysis of risk factors and management.

J Thorac Cardiovasc

Surg

1996;

112

(6): 1600–1607; discussion 1607–1609. DOI: 10.1016/

s0022-5223(96)70019-3.

18. Blount S, Vogel J. Pulmonary hypertension. In: Moss A, Adams F, eds.

Heart Disease in Infants, Children, and Adolescents

. Baltimore: Williams

and Wilkins, 1968: 947.

19. Bader H. Importance of the gerontology of elastic arteries in the

development of essential hypertension

. Clin Physiol Biochem

1983;

1

(1):

36–56. PMID: 6679476.

…continued from page 150

Applications and supporting documents should be submitted to

World Heart Federation; ‘CSIA Proposals’, 32 rue de Malatrex,

1201 Geneva, Switzerland. e-mail

kate.ralston@worldheart.org

If you have any queries, please contact Chip Bollman at

cbolman46@gmail.com

more information on CSIA, visit

www.CSIAforRHD.org